𝔖 Bobbio Scriptorium

✦ LIBER ✦

Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications

✍ Scribed by Satomi Onoue; Shingen Misaka; Shizuo Yamada

Book ID: 105876734
Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 321 KB
Volume: 377
Category: Article
ISSN: 0028-1298
DOI: 10.1007/s00210-007-0232-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Structure-activity relationship of synth

Structure-activity relationship of synthetic truncated analogues of vasoactive intestinal peptide (VIP): an enhancement in the activity by a substitution with arginine

✍ Satomi Onoue; Yuki Ohmori; Asami Matsumoto; Shizuo Yamada; Ryohei Kimura; Takehi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Site-directed mutagenesis provides evide

Site-directed mutagenesis provides evidence for diffrence in the structure-function relationship of human vasoactive intestinal peptide (VIP) 1 and 2 receptor subtypes

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 105 KB

ChemInform Abstract: Synthesis, Structur

ChemInform Abstract: Synthesis, Structure-Activity Relationships, and Pharmacological Evaluation of Pyrrolo(3,2,1-ij)quinoline Derivatives: Potent Histamine and Platelet Activating Factor Antagonism and 5-Lipoxygenase Inhibitory Properties. Potential Therapeutic Application in Asthma

✍ D. PARIS; M. COTTIN; P. DEMONCHAUX; G. AUGERT; P. DUPASSIEUX; P. LENOIR; M. J. P 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB

Discovery of 1-[1-(1-Methylcyclooctyl)-4

Discovery of 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: Integrated Drug-Design and Structure–Activity Relationships for Orally Potent, Metabolically Stable and Potential-Risk Reduced Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist as Antianxiety Drug

✍ Shigeo Hayashi; Akiko Hirao; Hiroshi Nakamura; Kenzo Yamamura; Kunihiko Mizuno; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB